{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:33:45Z","timestamp":1784014425856,"version":"3.55.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1083057"],"award-info":[{"award-number":["1083057"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1048972"],"award-info":[{"award-number":["1048972"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1021607"],"award-info":[{"award-number":["1021607"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1062607"],"award-info":[{"award-number":["1062607"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP1211465"],"award-info":[{"award-number":["DP1211465"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP150103345"],"award-info":[{"award-number":["DP150103345"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP1096029"],"award-info":[{"award-number":["DP1096029"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP150104672"],"award-info":[{"award-number":["DP150104672"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001184","name":"Cure Cancer Australia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001184","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004365","name":"Sydney Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008718","name":"Judith Jane Mason and Harold Stannett Williams Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejmech.2017.08.021","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T04:47:15Z","timestamp":1502254035000},"page":"612-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"139","author":[{"given":"Duraippandi","family":"Palanimuthu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachal","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8696-4948","authenticated-orcid":false,"given":"Rukhsana","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul V.","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta S.","family":"Kalinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Des R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.08.021_bib1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/15680266113139990135","article-title":"The multifactorial nature of Alzheimer's disease for developing potential therapeutics","volume":"13","author":"Carreiras","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2017.08.021_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hipo.450010102","article-title":"Entorhinal cortex pathology in Alzheimer's disease","volume":"1","author":"Van Hoesen","year":"1991","journal-title":"Hippocampus"},{"key":"10.1016\/j.ejmech.2017.08.021_bib4","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2017.08.021_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejmech.2017.08.021_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2012.10.558","article-title":"Metallostasis in Alzheimer's disease","volume":"62","author":"Ayton","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2017.08.021_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","article-title":"Alzheimer's disease: abeta, tau and synaptic dysfunction","volume":"11","author":"LaFerla","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2017.08.021_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2017.08.021_bib9","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1242\/jcs.019265","article-title":"Autophagy, amyloidogenesis and Alzheimer disease","volume":"120","author":"Nixon","year":"2007","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2017.08.021_bib10","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.08.021_bib11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.08.021_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0301-0082(99)00023-4","article-title":"The cause of neuronal degeneration in Alzheimer's disease","volume":"60","author":"Vickers","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40520-015-0321-8","article-title":"Evaluation of the cholinergic hypothesis in Alzheimer's disease with neuropsychological methods","volume":"27","author":"Fotiou","year":"2015","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.ejmech.2017.08.021_bib14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2017.08.021_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13543784.2016.1216972","article-title":"Old and new acetylcholinesterase inhibitors for Alzheimer's disease","volume":"25","author":"Galimberti","year":"2016","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2017.08.021_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A\u00a0review on cholinesterase inhibitors for Alzheimer's disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejmech.2017.08.021_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/v10007-011-0006-6","article-title":"Metal ions, Alzheimer's disease and chelation therapy","volume":"61","author":"Budimir","year":"2011","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2017.08.021_bib18","doi-asserted-by":"crossref","first-page":"52088","DOI":"10.1039\/C4RA09193K","article-title":"Drug-like chelating agents: a potential lead for Alzheimer's disease","volume":"4","author":"Huang","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2017.08.021_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ejmech.2017.08.021_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1471-4159.2002.t01-1-01061.x","article-title":"Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease","volume":"82","author":"Yamamoto","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-2009-1068","article-title":"Challenges associated with metal chelation therapy in Alzheimer's disease","volume":"17","author":"Hegde","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2017.08.021_bib22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimers disease","volume":"337","author":"Mclachlan","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2017.08.021_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2017.08.021_bib24","first-page":"CD005380","article-title":"Metal protein attenuating compounds for the treatment of Alzheimer's dementia","author":"Sampson","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2017.08.021_bib25","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/ejn.12169","article-title":"Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification","volume":"37","author":"Wolfe","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2017.08.021_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s13311-014-0320-z","article-title":"Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease","volume":"12","author":"Friedman","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2017.08.021_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.celrep.2013.08.042","article-title":"Abeta secretion and plaque formation depend on autophagy","volume":"5","author":"Nilsson","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2017.08.021_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1570159X113116660047","article-title":"Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer's disease","volume":"12","author":"Agis-Torres","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/molecules21040466","article-title":"Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer's disease","volume":"21","author":"Prati","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.08.021_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2174\/1570159X14666160119094820","article-title":"AChE inhibition-based multi-target-directed ligands, a novel pharmacological approach for the symptomatic and disease-modifying therapy of Alzheimer's disease","volume":"14","author":"Wang","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1570159X1203140511153200","article-title":"Multi-target directed drugs: a modern approach for design of new drugs for the treatment of Alzheimer's disease","volume":"12","author":"Dias","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib32","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ejmech.2016.12.009","article-title":"Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-beta-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease","volume":"126","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib33","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.bmc.2017.02.049","article-title":"Design, synthesis and biological evaluation of multifunctional tacrine-curcumin hybrids as new cholinesterase inhibitors with metal ions-chelating and neuroprotective property","volume":"25","author":"Liu","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejmech.2016.04.053","article-title":"Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies","volume":"119","author":"Kumar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejmech.2017.02.043","article-title":"Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease","volume":"130","author":"Dias","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2016.10.060","article-title":"A\u00a0review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease","volume":"128","author":"Sameem","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejmech.2014.04.078","article-title":"Donepezil\u00a0+ propargylamine\u00a0+ 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease","volume":"80","author":"Wang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejmech.2016.07.052","article-title":"Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"123","author":"Wang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib39","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cmdc.201600014","article-title":"Novel 8-hydroxyquinoline derivatives as multitarget compounds for the treatment of Alzheimer's disease","volume":"11","author":"Prati","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2017.08.021_bib40","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1021\/jm900504c","article-title":"Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy","volume":"52","author":"Zheng","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/156802611794785190","article-title":"The medicinal chemistry of novel iron chelators for the treatment of cancer","volume":"11","author":"Kovacevic","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib42","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/jm900552r","article-title":"Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors","volume":"52","author":"Yu","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib43","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","article-title":"Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in\u00a0vitro and in\u00a0vivo assessment","volume":"104","author":"Yuan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2017.08.021_bib44","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A\u00a0class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2017.08.021_bib45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood.V100.2.666","article-title":"Novel \u201chybrid\u201d iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells","volume":"100","author":"Lovejoy","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2017.08.021_bib46","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/cr300009x","article-title":"Bioinorganic chemistry of Alzheimer's disease","volume":"112","author":"Kepp","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2017.08.021_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jinorgbio.2014.04.011","article-title":"8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated A\u03b2 peptide aggregation","volume":"139","author":"Gomes","year":"2014","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","article-title":"Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs","volume":"7","author":"Kryger","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2017.08.021_bib49","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10426509108233920","article-title":"A\u00a0facile synthesis of thiosemicarbazides and thiosemicarbazones by the transamination of 4-methyl-4-phenyl-3-thiosemicarbazide","volume":"60","author":"Scovill","year":"1991","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib51","doi-asserted-by":"crossref","first-page":"9309","DOI":"10.1021\/ic300967j","article-title":"L- and D-proline thiosemicarbazone conjugates: coordination behavior in solution and the effect of copper(II) coordination on their antiproliferative activity","volume":"51","author":"Milunovic","year":"2012","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib52","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ica.2014.08.056","article-title":"Novel Fe(III), Co(III), Ni(II), Cu(II) coordination compounds involving 2-[(2-hydroxyphenyl)methylene]hydrazine-N-(2-propenyl)carbothioamide as ligand: synthesis, crystal structures and spectral characteristics","volume":"423","author":"Orysyk","year":"2014","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ejmech.2017.08.021_bib53","doi-asserted-by":"crossref","first-page":"13427","DOI":"10.1039\/C6DT02784A","article-title":"Structure-antiproliferative activity studies on l-proline- and homoproline-4-N-pyrrolidine-3-thiosemicarbazone hybrids and their nickel(II), palladium(II) and copper(II) complexes","volume":"45","author":"Dobrova","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2017.08.021_bib54","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1021\/jm0606342","article-title":"Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity","volume":"49","author":"Richardson","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib55","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1158\/0008-5472.CAN-11-1218","article-title":"Antitumor activity of metal-chelating compound Dp44mT Is mediated by formation of a redox-active copper complex that accumulates in lysosomes","volume":"71","author":"Lovejoy","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2017.08.021_bib56","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1021\/jm070445z","article-title":"Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents","volume":"50","author":"Kalinowski","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib57","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/jm801585u","article-title":"2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity","volume":"52","author":"Richardson","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib58","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00702-014-1319-7","article-title":"In\u00a0vitro streptozotocin model for modeling Alzheimer-like changes: effect on amyloid precursor protein secretases and glycogen synthase kinase-3","volume":"122","author":"Plaschke","year":"2015","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.ejmech.2017.08.021_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10495-006-0524-8","article-title":"Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress","volume":"12","author":"Chan","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2017.08.021_bib60","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/pr.57.4.2","article-title":"The evolution of iron chelators for the treatment of iron overload disease and cancer","volume":"57","author":"Kalinowski","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2017.08.021_bib61","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1182\/blood.V86.11.4295.bloodjournal86114295","article-title":"The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents","volume":"86","author":"Richardson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2017.08.021_bib62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/acs.jmedchem.5b01399","article-title":"Novel mechanism of cytotoxicity for the selective selenosemicarbazone, 2-acetylpyridine 4,4-dimethyl-3-selenosemicarbazone (Ap44mSe): lysosomal membrane permeabilization","volume":"59","author":"Al-Eisawi","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib63","first-page":"34","article-title":"A\u00a0delicate balance: iron metabolism and diseases of the brain, Front","volume":"5","author":"Hare","year":"2013","journal-title":"Aging Neurosci."},{"key":"10.1016\/j.ejmech.2017.08.021_bib64","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ajh.10348","article-title":"Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity","volume":"73","author":"Chaston","year":"2003","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib65","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer's disease","volume":"337","author":"Crapper McLachlan","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2017.08.021_bib66","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pneurobio.2007.06.001","article-title":"Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents","volume":"82","author":"Mandel","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib67","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V89.8.3025","article-title":"The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone","volume":"89","author":"Richardson","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2017.08.021_bib68","first-page":"660","article-title":"The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis","volume":"124","author":"Richardson","year":"1994","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.ejmech.2017.08.021_bib69","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/jm7012562","article-title":"Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series","volume":"51","author":"Kalinowski","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brainres.2010.05.090","article-title":"Vitamin C distribution and retention in the mouse brain","volume":"1348","author":"Harrison","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2017.08.021_bib71","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2008.12.018","article-title":"Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2","volume":"46","author":"Harrison","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2017.08.021_bib72","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/acschemneuro.5b00106","article-title":"Ascorbate protects neurons against oxidative stress: a Raman microspectroscopic study","volume":"6","author":"Dutta","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2017.08.021_bib73","first-page":"402","article-title":"Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311","volume":"9","author":"Chaston","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2017.08.021_bib74","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1021\/acs.jmedchem.6b00426","article-title":"Benzylpiperidine-linked diarylthiazoles as potential anti-Alzheimer's agents: synthesis and biological evaluation","volume":"59","author":"Shidore","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.med.57.121304.131442","article-title":"Current pharmacotherapy for Alzheimer's disease","volume":"57","author":"Lleo","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejmech.2017.08.021_bib76","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejmech.2013.09.050","article-title":"Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection","volume":"70","author":"Singh","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib78","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1016\/j.bmc.2013.05.028","article-title":"Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease","volume":"21","author":"Keri","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib79","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.0959-9673.2005.00434.x","article-title":"Metals and amyloid-beta in Alzheimer's disease","volume":"86","author":"Maynard","year":"2005","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib81","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nurt.2008.05.001","article-title":"Therapeutics for Alzheimer's disease based on the metal hypothesis","volume":"5","author":"Bush","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2017.08.021_bib82","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1002\/elps.201200307","article-title":"Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia","volume":"33","author":"Albertini","year":"2012","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ejmech.2017.08.021_bib83","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/anie.200603866","article-title":"Combating Alzheimer's disease with multifunctional molecules designed for metal passivation","volume":"46","author":"Schugar","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2017.08.021_bib84","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1039\/c2mt20113e","article-title":"Dual-function triazole-pyridine derivatives as inhibitors of metal-induced amyloid-beta aggregation","volume":"4","author":"Jones","year":"2012","journal-title":"Metallomics"},{"key":"10.1016\/j.ejmech.2017.08.021_bib85","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/00207454.2010.505353","article-title":"Hypothesis on the relationship between the change in intracellular pH and incidence of sporadic Alzheimer's disease or vascular dementia","volume":"120","author":"Fang","year":"2010","journal-title":"Int. J. NeuroSci."},{"key":"10.1016\/j.ejmech.2017.08.021_bib86","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A\u00a0class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.08.021_bib87","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00030.2009","article-title":"Regulation of mammalian autophagy in physiology and pathophysiology","volume":"90","author":"Ravikumar","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2017.08.021_bib88","first-page":"443","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"12","author":"Kliosnky","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2017.08.021_bib89","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.1074\/jbc.M113.529511","article-title":"The metastasis suppressor, N-myc downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cells","volume":"289","author":"Sahni","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib90","doi-asserted-by":"crossref","first-page":"33568","DOI":"10.1074\/jbc.M114.599480","article-title":"The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity","volume":"289","author":"Gutierrez","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib92","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/js980402t","article-title":"Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration","volume":"88","author":"Clark","year":"1999","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2017.08.021_bib93","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/jm060642i","article-title":"Structure-brain exposure relationships","volume":"49","author":"Hitchcock","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib94","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A\u00a0short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.ejmech.2017.08.021_bib95","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1107\/S0021889899006020","article-title":"WinGX suite for small-molecule single-crystal crystallography","volume":"32","author":"Farrugia","year":"1999","journal-title":"J.\u00a0Appl. Cryst."},{"key":"10.1016\/j.ejmech.2017.08.021_bib96","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1107\/S0021889897003117","article-title":"ORTEP-3 for windows-a version of ORTEP-III with a graphical user interface (GUI)","volume":"30","author":"Farrugia","year":"1997","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2017.08.021_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4889(90)90018-9","article-title":"The uptake of iron and transferrin by the human malignant melanoma cell","volume":"1053","author":"Richardson","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2017.08.021_bib98","doi-asserted-by":"crossref","first-page":"13972","DOI":"10.1016\/S0021-9258(19)49665-8","article-title":"Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate","volume":"267","author":"Richardson","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib99","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.1840150323","article-title":"Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture","volume":"15","author":"Baker","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2017.08.021_bib100","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1016\/S0021-9258(17)44637-0","article-title":"The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes","volume":"258","author":"Iacopetta","year":"1983","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib101","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1021\/acs.jmedchem.6b00562","article-title":"Exploring basic tail modifications of coumarin-based dual acetylcholinesterase-monoamine oxidase B inhibitors: identification of water-soluble, brain-permeant neuroprotective multitarget agents","volume":"59","author":"Pisani","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib102","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/14756366.2010.529806","article-title":"Bifunctional phenolic-choline conjugates as anti-oxidants and acetylcholinesterase inhibitors","volume":"26","author":"Sebestik","year":"2011","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.021_bib103","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1039\/c3dt50406a","article-title":"Multifunctional iron-chelators with protective roles against neurodegenerative diseases","volume":"42","author":"Nunes","year":"2013","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2017.08.021_bib104","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.021_bib105","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10822-012-9575-9","article-title":"Docking performance of the glide program as evaluated on the Astex and DUD datasets: a complete set of glide SP results and selected results for a new scoring function integrating WaterMap and glide","volume":"26","author":"Repasky","year":"2012","journal-title":"J.\u00a0Computer-Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2017.08.021_bib106","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V98.3.842","article-title":"The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: the mechanisms involved in inhibiting cell-cycle progression","volume":"98","author":"Gao","year":"2001","journal-title":"Blood"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417306244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417306244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:57:21Z","timestamp":1777528641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417306244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":106,"alternative-id":["S0223523417306244"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.08.021","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}